Blueshift Asset Management’s Evolent Health EVH Stock Holding History

Blueshift Asset Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-36,480	Closed	-$1.18M	–	776
2022 Q1	$1.18M	Buy	+36,480	New	+$955K	0.11%	248
2021 Q3	–	Sell	-18,184	Closed	-$384K	–	1080
2021 Q2	$384K	Buy	+18,184	New	+$364K	0.02%	651
2019 Q3	–	Sell	-20,937	Closed	-$166K	–	789
2019 Q2	$166K	Sell	20,937 -49,961	-70%	-$592K	0.02%	669
2019 Q1	$892K	Buy	70,898 +41,107	+138%	+$651K	0.13%	268
2018 Q4	$594K	Buy	+29,791	New	+$689K	0.11%	308

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Blueshift Asset Management's EVH Position: Q2 2022 in Review

Blueshift Asset Management sold out of Evolent Health (EVH) in Q2 2022, closing a stake of 36,480 shares — an estimated $1.18M sold.

Blueshift Asset Management first reported a position in EVH in Q4 2018 and held it in 5 quarters. The position peaked at $1.18M in Q1 2022. 215 funds tracked by Wall St. Rank hold EVH as of Q2 2022.

Blueshift Asset Management reported no remaining Evolent Health position as of Q2 2022 after selling out during the quarter.
Blueshift Asset Management sold 36,480 Evolent Health shares in Q2 2022, an estimated $1.18M.
Blueshift Asset Management first reported a position in Evolent Health in Q4 2018 and held it in 5 quarters.
Blueshift Asset Management's Evolent Health position peaked at $1.18M in Q1 2022.
215 funds tracked by Wall St. Rank held Evolent Health as of Q2 2022.

Based on Blueshift Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.